Evaluating the Effect of Expressed Breast Milk and 10% Dextrose in Procedural Pain Relief in Neonates

Read full text
Authors: Richa Baniya, Shraddha Dangol, Sagun Manandhar, Samprada Tripathee, Ashram Poudel Upadhyaya, Sabina Shrestha
Cited by: 1

Abstract

BACKGROUND: In neonates painful procedures are performed with minimum to no regard for pain relief. Even if neonates are unable to communicate pain, it doesn't negate their ability to experience it. This study observed the effect of expressed breast milk (EBM) and 10% dextrose (10%D) during venipuncture in neonates. METHODS: A hospital based cross sectional comparative study was conducted from November 2021 to October 2022. Purposive sampling of 110 neonates who received expressed breast milk and 10% dextrose were assessed via Premature Infant Pain Profile - Revised (PIPP-R) pain assessment tool along with heart rate (HR), oxygen saturation (SpO2) and duration of cry. Data was collected and analyzed via independent t test using Statistical Package for Social Sciences version 25. RESULTS: The mean ± standard deviation of heart rate and oxygen saturation in expressed breast milk group was 168.57 ± 8.9 per minutes (min) and 95.31 ± 1.42% and in 10% dextrose group was 174.27 ± 9.02 per min and 93.80 ± 1.15% respectively. Mean duration of cry in expressed breast milk group was 51.89 ± 16.66 seconds (sec) and 10% dextrose group was 73.55 ± 24.05 sec with a significant difference (p=0.001). The premature infant pain profile revised score was recorded at 30 sec, 1 min and 3 min and 5 min and a significant difference was noted at 30 sec (p=0.000) and 1 min (p=0.047) after venipuncture. CONCLUSIONS: Expressed breast milk have better analgesic effect than 10% dextrose.

Fields of Study & Subjects

Pediatric Pain Management Techniques Infant Health and Development Breastfeeding Practices and Influences

Publication details

Journal / source
Journal of Nepal Health Research Council
Publisher
Nepal Health Research Council
Volume
23
Issue
04
Pages
604–609
Publication date
24 March 2026
Language
EN